Recursion Pharmaceuticals... (RXRX)
undefined
undefined%
At close: undefined
7.00
0.86%
After-hours Dec 13, 2024, 07:59 PM EST

Balance Sheet (Annual)

Get detailed breakdowns of the balance-sheet with total debts, total investments, and much more.
Year FY23 FY22 FY21 FY20 FY19
Cash & Equivalents 391.56M 549.91M 285.12M 262.13M 69.88M
Short-Term Investments - - 231.45M - -
Long-Term Investments - 7.92M 8.68M - -
Other Long-Term Assets 6.89M 7.92M 8.72M 650.00K 663.00K
Receivables 3.09M 2.75M 9.09M 156.00K 151.00K
Inventory - 1.28M 1.55M 5.04M 5.29M
Other Current Assets 43.48M 17.15M 9.07M 2.16M 1.08M
Total Current Assets 438.14M 569.81M 534.72M 269.48M 76.40M
Property-Plant & Equipment 120.17M 121.45M 64.72M 25.97M 24.37M
Goodwill & Intangibles 88.50M 2.11M 2.19M 2.49M -
Total Long-Term Assets 215.56M 131.47M 75.63M 29.11M 25.03M
Total Assets 653.70M 701.29M 610.35M 298.58M 101.43M
Account Payables 3.95M 4.59M 2.82M 1.07M 1.26M
Deferred Revenue 36.43M 56.73M 10.00M 10.00M -
Short-Term Debt 12.27M 12.00M 1.51M 2.01M 77.00K
Other Current Liabilities 40.52M 26.95M 32.33M 19.74M 5.05M
Total Current Liabilities 93.17M 100.27M 46.66M 23.10M 6.68M
Long-Term Debt 44.52M 44.96M 9.97M 14.12M 15.63M
Other Long-Term Liabilities - - 4.11M 450.99M 203.39M
Total Long-Term Liabilities 97.09M 115.22M 20.75M 481.77M 219.01M
Total Liabilities 190.26M 215.48M 67.41M 504.87M 225.70M
Total Debt 50.67M 51.01M 11.48M 15.66M 16.17M
Common Stock 2.00K 2.00K 2.00K - -
Retained Earnings -967.62M -639.56M -400.08M -213.60M -126.59M
Comprehensive Income -0.00 0.00 -126.00K - -
Shareholders Equity 463.44M 485.81M 542.94M -206.29M -124.27M
Total Investments 6.63M 7.92M 231.45M - -